Cite
HARVARD Citation
Bashash, D. et al. (2017). Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib. International journal of biochemistry & cell biology. pp. 149-158. [Online].